Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 18 Endometrial Neoplasms 4 Prostatic Neoplasms 3 Sarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Esophageal Neoplasms 2 Endometrial Clear Cell Adenocarcinoma 2 Vaginal Neoplasms 1 Uveitis 1 Uveal Melanoma 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Radiation Injuries 1 Obesity 1 Neurotoxicity Syndromes 1 Neoplasms, Unknown Primary 1 Malignant mesenchymal tumor 1 Lung Neoplasms 1 Locally Advanced Cervical Cancer 1 Locally Advanced Cervical Adenocarcinoma 1 Liver Neoplasms 1 Liposarcoma 1 Hyperthermia 1 Hemangiosarcoma 1 Hemangiopericytoma, Malignant 1 Head and Neck Neoplasms 1 Fibrosarcoma 1 Fatigue 1 Esophageal Squamous Cell Carcinoma 1

Interventions

Diathermy 3 Drug Therapy 2 Radiotherapy 1 Radiation 1 Mitomycin 1 Gemcitabine 1 Fluorouracil 1 Doxorubicin 1 Cytoreduction Surgical Procedures 1 Conization 1 Cisplatin 1 Capecitabine 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hyperthermia × Brachytherapy × Clear all

NCT03332069 2017-11-07

mEHT

University of Witwatersrand, South Africa

Phase 3 Unknown

Hyperthermia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡